Myriad Genetics
MYGN
MYGN
284 hedge funds and large institutions have $3.48B invested in Myriad Genetics in 2018 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 93 increasing their positions, 83 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.43% more ownership
Funds ownership: 105.08% → 106.52% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
55% less call options, than puts
Call options by funds: $9.89M | Put options by funds: $22.2M
Holders
284
Holding in Top 10
1
Calls
$9.89M
Puts
$22.2M
Top Buyers
| 1 | +$75.7M | |
| 2 | +$29.3M | |
| 3 | +$18.6M | |
| 4 |
Morgan Stanley
New York
|
+$17.8M |
| 5 |
BlackRock
New York
|
+$17.6M |
Top Sellers
| 1 | -$56.1M | |
| 2 | -$22.3M | |
| 3 | -$19.7M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$19M |
| 5 |
Goldman Sachs
New York
|
-$16M |